Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism
- 47 Downloads
The calcium-sensing receptor (CaR) polymorphism A986S has been found to be associated with higher serum calcium levels in normal subjects, suggesting that this amino acid change might decrease the inhibitory activity of the mutated receptor, render the parathyroid cells more prone to proliferate, and eventually increase the risk of developing primary hyperparathyroidism (PHPT). The aim of the present study was to investigate the frequency of this and other 2 known CaR polymorphisms (R990G and Q1011E) in patients with PHPT and their effect on its phenotype. We studied 103 Italian patients with PHPT and 148 healthy Italian subjects and we compared the results in 50 pairs matched for sex, age and geographic provenience. A fragment of exon 7 of the CaR gene, containing the 3 polymorphic loci of interest (A986S, R990G, and Q1011E), was amplified by PCR and sequenced. Serum calcium and PTH levels, BMD and other biochemical and clinical parameters were evaluated. The frequency distribution of the A986S, R990G, and Q1011E polymorphisms in the 103 PHPT patients was 39.8%, 5.8%, and 2.0%, respectively. There was no difference in the frequency of the 3 CaR polymorphisms in the 50 matched pairs of patients and controls. We found no significant difference in several clinical and biochemical parameters between PHPT patients carrying or not the 986S allele. Finally, no relationship was observed between the 986S genotype and total and ionized serum calcium in control subjects. The A986S CaR polymorphism is the most common in Italian PHPT patients and the allotype AS does not appear to play a relevant role in the pathogenesis of PHPT and its severity. The A986S polymorphism does not correlate with serum calcium levels in normal Italian subjects.
Key-wordsCalcium-sensing receptor polymorphism primary hyperparathyroidism parathyroid tumors
Unable to display preview. Download preview PDF.
- 2.Pearce S.H.S., Thakker R.V. The calcium-sensing receptor: insight into extracellular calcium homeostasis in health and disease. J. Endocrinol. 1997, 99: 88–96.Google Scholar
- 20.Potts J.T. (Ed). NIH Consensus Development Conference Statement on Primary Hyperparathyroidism. J. Bone Miner. Res. 1991, 6: S9–S13.Google Scholar
- 22.Sambrook J., Fitsch E.F., Maniatis T. Molecular cloning: A laboratory manual 2nd ed., Cold Spring Harbor laboratory, Cold Spring Harbor, New York, 1989, vol 1, 2, E3–E5.Google Scholar
- 23.Bilezikian J.P., Silverberg S.J., Gartenberg F. et al. Clinical presentation of primary hyperparathyroidism. In: Bilezikian J.P., Levine M.A., Marcus R. (Eds.), The Parathyroids. Raven Press, Ltd., New York, 2001, p 457.Google Scholar
- 27.Khosla S., Ebeling P.R., Firek A.F., Burritt M.M., Kao P.C., Heath III H. Calcium infusion suggests a “set-point” abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism J. Clin. Endocrinol. Metab. 1993, 76: 715–720.PubMedGoogle Scholar